NEW YORK (
CHANGE IN RATINGS
(ADVS - Get Report)
was downgraded at JMP Securities from outperform to market perform. Company is facing near-term demand uncertainty, JMP said.
(BIDU - Get Report)
was downgraded at Citigroup from buy to sell. $95.10 price target. Company is seeing lower sales, Citi said.
was upgraded at Robert Baird from neutral to outperform. $33 price target. Company should benefit from auction of salvage vehicles, Robert Baird said.
(F - Get Report)
was upgraded at Craig Hallum to buy from hold. $14 price target. Company is seeing higher growth in North America, Hallum said.
was initiated with a neutral rating at UBS. $81 price target. Company faces regulatory headwinds, UBS said.
was upgraded at JP Morgan to overweight.
was initiated with a buy rating at Goldman Sachs. $40 price target. Company was also placed on the Conviction List, Goldman said. Pullback has created an attractive entry point, Goldman added.
was downgraded at Deutsche Bank from buy to hold. $11 price target. Company is unlikely to receive a competing bid, Deutsche said.
(RVBD - Get Report)
was downgraded at Jefferies from hold to underperform. $16.25 price target. Company is paying a premium for
, Jefferies said.
Riverbed was downgraded at Robert Baird from outperform to neutral. $24 price target. Company is leveraged to a weaker macro outlook, Baird said.
(WU - Get Report)
was downgraded at William Blair to market perform. Mexico business is slowing down, Blair said.
Western Union was downgraded at DA Davidson to underperform. $15 price target. Company is facing economic, regulatory and competitive pressure, DA Davidson said.
STOCK COMMENTS / EPS CHANGES
numbers were boosted at BofA/Merrill. Shares are now seen reaching $134. Estimates also upped, as the recent acquisition should add to earnings, BofA/Merrill said. Buy rating.
Ford estimates, price target were raised at UBS. Shares are now seen reaching $15. Estimates were also increased, given the company's new guidance, UBS said. Buy rating.
numbers were cut at UBS. Estimates were reduced through 2014. Company has limited near-term visibility, UBS said. Buy rating and new $13 price target.